Columbus Circle Investors’s Repligen RGEN Stock Holding History
Bought
Maintained
Sold
Other funds holding RGEN
FAM
1WCM
Columbus Circle Investors's RGEN Position: Q4 2020 in Review
Columbus Circle Investors increased its Repligen (RGEN) stake by 0.48% in Q4 2020, buying an estimated $51.7K and bringing the position to 59,147 shares worth $11.3M. The position accounts for 0.5% of the portfolio, ranked #83.
Columbus Circle Investors first reported a position in RGEN in Q2 2015 and has held it in 8 quarters since. The position peaked at $16.2M in Q4 2015. 449 funds tracked by Wall St. Rank hold RGEN as of Q4 2020.
- Columbus Circle Investors held 59,147 shares of Repligen worth $11.3M as of Q4 2020.
- Columbus Circle Investors bought 284 Repligen shares in Q4 2020, an estimated $51.7K.
- Repligen made up 0.5% of Columbus Circle Investors's portfolio in Q4 2020, its #83 holding.
- Columbus Circle Investors first reported a position in Repligen in Q2 2015 and has held it in 8 quarters since.
- Columbus Circle Investors's Repligen position peaked at $16.2M in Q4 2015.
- 449 funds tracked by Wall St. Rank held Repligen as of Q4 2020.
Based on Columbus Circle Investors's 13F filing for Q4 2020, filed 20 Jan 2021.